162
Participants
Start Date
May 31, 2025
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Amoxicillin
Participants in this group will receive oral amoxicillin at a dosage of 30mg/kg/day. The treatment will be administered in divided doses for the duration of the study, with the aim of resolving symptoms of acute otitis media in children.
Clavulanic Acid
Participants in this group will receive a combination of oral amoxicillin and clavulanic acid at a dosage of 30mg/kg/day. The medication will be given in divided doses, and participants will be monitored for symptom resolution and any potential side effects.
University of Health Sciences Lahore
OTHER